ga

Skip to content

My Files [0]

These are the files you have added to your collection.

  • You don't have any documents yet, feel free to browse the website and add documents.

CADTH » Search All Products » Health Technology Assessment » Addendum to the Canadian Agency for Drugs and Technologies in Health Guidelines for the Economic Evaluation of Health Technologies: Specific Guidance for Oncology Products

Addendum to the Canadian Agency for Drugs and Technologies in Health Guidelines for the Economic Evaluation of Health Technologies: Specific Guidance for Oncology Products

This addendum to CADTH’s Guidelines for the Economic Evaluation of Health Technologies (3rd Edition) is intended to provide specific guidance on the methods used to conduct high-quality economic evaluations of oncology products.

The oncology-specific guidelines should be considered a companion document to CADTH’s Guidelines for the Economic Evaluation of Health Technologies (3rd Edition). The development of these guidelines was led by members of the Working Group on Economic Analysis (WGEA) from the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG).

Report

This report has been extensively peer-reviewed by external clinical and methodological experts.

Report (50 pages)

Summary

Introduction (3 pages)